RxDoctor Payments Data

Victoria Cruz, PA

Physician Assistant · Brandon, FLNPI 1396371878

Payments from drug & device makers

$1,511in general payments, 2019–2025

Across 59 payments — averaging $25.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$535
  • Otsuka America Pharmaceutical, Inc.$300
  • Axsome Therapeutics, Inc.$271
  • Lundbeck LLC$91
  • Noven Therapeutics, LLC$72
  • Almatica Pharma LLC$71
  • plus $171 from 6 others

What the payments were for

  • Food & beverage$1,511100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,511 in reported general payments places this provider in the 70th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$22,318
Medicare patients
55
Services billed
471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole13$31,776
Fluvoxamine Maleate14$1,912
Desvenlafaxine Succinate ErDesvenlafaxine Succinate40$1,338
Prazosin Hcl52$1,240
Bupropion XlBupropion Hcl42$1,060
Venlafaxine Hcl17$826
Mirtazapine35$788
Clonazepam58$786
Aripiprazole25$764
Fluoxetine Hcl22$754
Trazodone Hcl87$727
Duloxetine Hcl28$676
Lamotrigine37$532
Escitalopram Oxalate44$467
Buspirone Hcl36$432

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$300$31,77613 claims
Almatica Pharma LLCSertraline Hcl$71$6813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →